April 24, 2019 – Model-Based Meta-Analysis (MBMA) is a growing methodology that leverages literature based and often external data to provide a quantitative framework to enable strategic drug development decisions. MBMA comparator models often include valuable pieces of information such as time, covariates, clinical trial efficacy and safety information.
Read MoreBuilding an MBMA Framework to Support Developing New Neuropathic Pain Drugs
0 comments.
Click here to read/write comments.
Topics: